A nurse-led, patient-centred mitoxantrone service in neurology

Area of Science:

• Neurology
• Immunology
• Pharmacology

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system.
• While treatments exist, some patients experience rapid disease progression.
• Mitoxantrone, a chemotherapy agent, shows efficacy in aggressive MS but requires cautious use due to side effects.

Purpose of the Study:

• To describe an MS nurse-led initiative.
• To present an evidence-based, integrated care pathway for mitoxantrone use in aggressive MS.
• To ensure safe and high-quality service provision for a select patient group.

Main Methods:

• Development of an evidence-based, integrated care pathway.
• Implementation of a nurse-led service model.
• Focus on a select group of patients with aggressive MS.

Main Results:

• The initiative established a structured approach to mitoxantrone administration.
• The integrated care pathway aimed to optimize patient safety and care quality.
• This model provides a framework for managing aggressive MS with cytotoxic agents.

Conclusions:

• Nurse-led initiatives can effectively manage complex treatments like mitoxantrone in MS.
• Integrated care pathways are crucial for safe and high-quality provision of care for aggressive MS.
• Careful consideration of risks and benefits is essential when using mitoxantrone for multiple sclerosis.